SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001193125-17-252879
Filing Date
2017-08-09
Accepted
2017-08-09 16:47:08
Documents
4

Document Format Files

Seq Description Document Type Size
1 424B3 d403494d424b3.htm 424B3 507339
2 GRAPHIC g403494g71a27.jpg GRAPHIC 34280
3 GRAPHIC g403494g81p64.jpg GRAPHIC 137895
4 GRAPHIC g403494g81r24.jpg GRAPHIC 31756
  Complete submission text file 0001193125-17-252879.txt   789595
Mailing Address 257 SIMARANO DRIVE SUITE 101 MARLBOROUGH MA 01752
Business Address 257 SIMARANO DRIVE SUITE 101 MARLBOROUGH MA 01752 (508) 767-3861
RXi Pharmaceuticals Corp (Filer) CIK: 0001533040 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-219300 | Film No.: 171018543
SIC: 2834 Pharmaceutical Preparations